Long-term Impact of Infection With Novel Coronavirus (COVID-19)
Recruiting now
Conditions studied: COVID
In brief
LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data. LIINC specimens will be used to examine multiple questions involving the virologic, immunologic, and host factors involved in COVID-19, with a focus on understanding variability in the long-term immune response between individuals.
Key facts
- Study ID
- NCT04362150
- Run by
- University of California, San Francisco
- People needed
- 800
- Starts
- 2020-04-21
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2026-07-23
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Willing and able to provide written informed consent, and
- Age >/= 18 years, and
- A history of SARS-CoV-2 infection, as evidenced by:
- Available laboratory documentation of SARS-CoV-2 RNA positivity on a nucleic acid amplification test or by serologic testing when this becomes available, or
- Reference by the participant to a laboratory test performed on respiratory tract secretions or blood, fingerstick, or saliva test that was reported to the participant to be positive for SARS-CoV-2 or COVID-19 infection,
- And a period of 21 days or more has elapsed since the first positive test or symptoms preceding the first positive test, whichever is earlier.
You may not qualify if…
- Self-reported or documented chronic anemia with hemoglobin < 9 g/dL. Anemia during a preceding acute illness will not be exclusionary.
- Serious medical or psychiatric illness that, in the opinion of the site investigator, would interfere with the ability to adhere to study requirements or to give informed consent.
- Active drug or alcohol use or dependence that, in the opinion of the Principal Investigator, would interfere with adherence to study requirements or to give informed consent.
Where it is running
- Zuckerberg San Francisco General Hospital (ZSFG) — San Francisco, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.